Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE Cause Graft versus host disease? 219 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 219 reports of Graft versus host disease have been filed in association with CYTARABINE (cytarabine). This represents 0.5% of all adverse event reports for CYTARABINE.

219
Reports of Graft versus host disease with CYTARABINE
0.5%
of all CYTARABINE reports
70
Deaths
64
Hospitalizations

How Dangerous Is Graft versus host disease From CYTARABINE?

Of the 219 reports, 70 (32.0%) resulted in death, 64 (29.2%) required hospitalization, and 18 (8.2%) were considered life-threatening.

Is Graft versus host disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 219 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE Cause?

Febrile neutropenia (6,142) Off label use (4,183) Pyrexia (2,992) Neutropenia (2,558) Disease progression (2,352) Drug ineffective (2,281) Thrombocytopenia (2,148) Sepsis (2,013) Myelosuppression (1,869) Product use in unapproved indication (1,619)

What Other Drugs Cause Graft versus host disease?

CYCLOSPORINE (1,131) TACROLIMUS (900) MYCOPHENOLATE MOFETIL (890) CYCLOPHOSPHAMIDE (653) METHOTREXATE (615) FLUDARABINE (541) BUSULFAN (507) RUXOLITINIB (469) METHYLPREDNISOLONE (429) PREDNISONE (405)

Which CYTARABINE Alternatives Have Lower Graft versus host disease Risk?

CYTARABINE vs CYTARABINE\DAUNORUBICIN CYTARABINE vs DABIGATRAN CYTARABINE vs DABIGATRAN ETEXILATE CYTARABINE vs DABRAFENIB CYTARABINE vs DABRAFENIB\TRAMETINIB

Related Pages

CYTARABINE Full Profile All Graft versus host disease Reports All Drugs Causing Graft versus host disease CYTARABINE Demographics